Synthesis of active metabolites of carvedilol, an antihypertensive drug

Synthetic Communications

Volumn 41, Issue 2, 2011, Pages 268-276

  Senthilkumar, N ^a   Somannavar, Y S ^a   Reddy, Shankar B ^a   Sinha, Brajesh Kumar ^a   Narayan, G K A S S ^a   Dandala, Ramesh ^a   Mukkanti, Kaga ^b  

^a Aurobindo Pharma Ltd   (India)

^b JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

Author keywords

4 oxiranylmethoxy 9H carbazole; Angina; antihypertension; carvedilol; congestive heart failure; metabolite

Indexed keywords

4' HYDROXYCARVEDILOL; 5' HYDROXYCARVEDILOL; CARVEDILOL; DRUG METABOLITE; ISOVANILLIN; UNCLASSIFIED DRUG; VANILLIN;

ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; DRUG ACTIVITY; DRUG SYNTHESIS;

EID: 78650270037     PISSN: 00397911     EISSN: 15322432     Source Type: Journal    
DOI: 10.1080/00397910903534072     Document Type: Article

References (13)

1. Packer, M.; Fowler, B. M.; Roecker, B. E.; Coats, J. S. A.; Katus, A. H.; Krum, H.; Mohacsi, P.; Rouleau, L. J.; Tendera, M.; Staiger, C; Holcslaw, L. T.; Amann-Zalan, I.; DeMets, L. D. Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study group: Effect of carvedilol on the morbidity of patients with severe chronic heart failure: Results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 2002,106(22), 2194-2199.
2. Ruffolo, R. R.; Boyle, D. A.; Brooks, D. P.; Feuerstein, G. Z.; Venuti, R. P.; Lukas, M. A.; Poste, G. Carvedilol: A novel cardiovascular drug with multiple actions. Cardiovasc. Drug Rev. 1992, 10, 127-157.
3. Schaefer, W. H.; Politowski, J.; Hwang, B.; Dixon, F. J.; Goalwin, A.; Gutzait, L.; Anderson, K.; Debrosse, C; Bean, M.; Rhodes, G. R. Metabolism of carvedilol in dogs, rats, and mice. Drug Metab. Dispos. 1998, 26, 958-969.
4. Nakamura, K.; Kusano, K.; Nakamura, Y.; Kakishita, M.; Ohta, K.; Nagase, S.; Yamamoto, M.; Miyaji, K.; Saito, H.; Morita, H.; Emori, T.; Matsubara, H.; Toyokuni, S.; Ohe, T. Carvedilol decreases elevated oxidative stress in human failing myocardium. Circulation 2002, 105, 2867-2871.
5. Kukin, L. M.; Kalman, J.; Charney, H. R.; Levy, K. D.; Buchholz-Varley, C; Ocampo, N. O. Prospective, randomized comparison of effect of long-term treatment with meto-prolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure. Eng. C Circulation 1999, 99, 2645-2651.
6. Poole-Wilson, P. A.; Swedberg, K.; Cleland, J. G.; Di Lenarda, A.; Hanrath, P.; Komajda, M.; Lubsen, J.; Lutiger, B.; Metra, M.; Remme, W. J.; Torp-Pedersen, C; Scherhag, A.; Skene, A. Rationale and design of the carvedilol or metoprolol tartrate European trial in patients with chronic heart failure: COMET. Eur. J. Heart. Fail. 2002, 4, 321-329.
7. Oldham, H. G.; Clarke, S. E. In vitro identification of the human cytochrome P450 enzymes involved in the metabolism of R(+)- and S(-)-carvedilol. Drug Metab. Dispos. 1997, 25, 970-977.
8. Jhy-Chong, L.; Jwu-Lai, Y.; Chia-Sui, W.; Shwu-Fen, L.; Chieh-Ho, T.; Ing-Jun, C. The new generation dihydropyridine-type calcium blockers, bearing 4-phenyl oxypropanola-mine, display a,b-adrenoceptor antagonist and long-acting antihypertensive activities. Bioorg. Med. Chem. Lett. 2002, 10, 719-730.
9. Dakin, H. D. The oxidation of hydroxyl derivatives of benzaldehyde, acetophenone, and related substances. Am. Chem. J. 1909, 42, 477-481.
10. Alker, D.; Arrowsmith, L. E.; Campbell, S. F.; Cross, P. E. Long-acting dihydropyridine calcium antagonists, IX: Structure-activity relationships around amlodipine. Eur. J. Med. Chem. 1991, 26, 907-913.
11. Trepat Guixer, E.; Munoz Alvarex, A.; Pomares Marco, M.; Marquillas Olondriz, F. Process for the preparation of carvedilol and its enantiomers. WO patent 2006061364, 2006; Chem. Abstr. 2006, 145, 62782.
12. KanKan, R. N.; Rao, D. R. Process for the preparation of carvedilol with improved yields on an industrial scale. WO Patent 2005113502, 2005; Chem. Abstr. 2006, 143, 266815.
13. Vijay, C. C.; Rajeev, B. R.; Rajamannar, T. A process for preparation of 1-[9 h-carbazol-4-yloxy]-3-[{2-(2-(methoxy)phenoxy)-ethyl}-amino]-propan-2-ol. US Patent 20060270858, 2006; Chem. Abstr. 2004, 142, 93675.